ArticleFrontiers in medicine2026
Trends in respiratory failure mortality in the United States from 1999 to 2023.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The U.S. population is aging, accompanied by concurrent increases in the burden of respiratory failure. However, respiratory failure-related mortality trends among 45 years old adults have not been investigated. The purpose of this study was to assess the trends and regional differences in respiratory failure-related mortality among older adults in the United States. Methods: Data were obtained from the CDC WONDER database, encompassing death records of U.S. residents aged 45 years and older between 1999 and 2023. Cases were identified in which respiratory failure (ICD-10 codes J96.0, J96.1, and J96.9) was documented as the cause of death. We computed both crude and age-adjusted mortality rates (AAMR) per 100,000 population and employed Joinpoint regression to estimate annual percentage changes (APC) and average annual percentage change (AAPC). Additionally, a sensitivity analysis was conducted in which lung cancer was identified as the underlying cause of death and respiratory failure as a contributing cause, to assess the robustness of the conclusions. Results: A total of 186,075 respiratory failure-related deaths were recorded within the study period. The AAMR increased markedly from 3.71 in 1999 to 10.50 in 2023. The most pronounced upward trend occurred between 2005 and 2018 (APC: +7.96%; 95% CI: 7.44 to 8.93; Conclusion: Respiratory failure-related mortality has risen substantially over the study period, particularly after 2005, with significant inequalities observed across racial, gender, and geographic subgroups. These findings highlight the urgent need for targeted public health interventions to mitigate the increasing burden of these conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.